Home / Erythropoietin / Belgium
BE ATC B03XA01 · updated 2 Nov 2026
Erythropoietin shortage in Belgium
Is there an Erythropoietin shortage in Belgium?
Yes. As of 2 Nov 2026, 3 Erythropoietin products are reported short in Belgium, the first since 10 Oct 2025. The company estimate for the return is 18 Nov 2026 (latest 31 Dec 2026). Main reason: other.
Also short in Canada, Germany, Italy, Spain, Sweden. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | NeoRecormon 10 000 IU (Abacus Medicine) inj. sol. s.c./i.v. pre-filled syr. 6 x 0.6 ml | Roche Registration | 10 Oct 2025 | 31 Dec 2026 | Other Other reason |
| BE | NeoRecormon 5 000 IU (Abacus Medicine) inj. sol. s.c./i.v. pre-filled syr. 6 x 0.3 ml | Roche Registration | 10 Oct 2025 | 31 Dec 2026 | Other Other reason |
| BE | Binocrit 10 000 IU/1 ml inj. sol. i.v./s.c. pre-filled syr. 6 x 1 ml | Sandoz | 4 Oct 2026 | 18 Nov 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.